Clinical Trial Update: Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study evaluating whether furosemide can prevent fluid overload during neonatal red blood cell transfusions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Disease

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Lung Disease | Phase 3 | Status: UNKNOWN